Endometrial hyperplasia and adenocarcinoma during tibolone (Livial®) therapy
Data up to Jan 2025
Total Citations Per Year
Abstract
References (14)
Cancer Incidence in Five Continents
1966 • 5,960 citations
Prospective double-blind trial of synthetic steroid (Org OD 14) for preventing postmenopausal osteoporosis.
1980 • 156 citations
Endometrial Histology and Biochemistry in Climacteric Women during Oestrogen and Oestrogen/Progestogen Therapy
1979 • 131 citations
British national formulary 1981, no. 1
1981 • 128 citations
Org OD 14 and the endometrium
1991 • 113 citations
Alpha fetoprotein: Physiology and pathology during pregnancy and application to antenatal diagnosis
1973 • 82 citations
The Prevention and Treatment of Endometrial Pathology in Postmenopausal Women receiving Exogenous Estrogens
1980 • 79 citations
Multicentre study of effects of Org OD 14 on endometrium, vaginal cytology and cervical mucus in post-menopausal and oophorectomized women
1984 • 64 citations
Pharmacological studies with (7α,17α)-17-hydroxy-7-methyl-19-norpregn-5(10)-en-20-yn-3-one (Org OD 14)
1987 • 53 citations
Use of Org OD 14 for the treatment of climacteric complaints
1987 • 36 citations
Elevated maternal serum alpha-fetoprotein and amniotic fluid alpha-fetoprotein after multifetal pregnancy reduction.
1990 • 25 citations
[Use of a new steroid (Org OD 14) in the climacteric syndrome].
1982 • 23 citations
Prolonged elevation of alphafetoprotein and detectable acetylcholinesterase after death of an anomalous twin fetus
1989 • 19 citations
Cancer and Other Risk Factors with Estrogen Replacement
1987 • 4 citations